CDRH Director and Industry Experts to Speak at MDMA CEO Forum

WASHINGTON, DC, September 17, 2008 – Medical device industry CEOs, experts and government officials will gather for the Medical Device Manufacturers Association (MDMA) Medical Technology Executive Forum: Key Commercialization Issues Impacting the Medical Device Industry on October 15th at the Crowne Plaza in Palo Alto, CA.

This one day interactive forum will provide CEOs and senior medical technology executives with a practical perspective on managing the key issues that directly impact successful product commercialization. Industry experts will address attracting and securing funding, recent developments at FDA, navigating reimbursement challenges, protecting and licensing IP and much more. In addition, speakers will discuss managing these key elements as a company plans for the successful launch of new products and technologies.

Meeting attendees will hear from the Director of CDRH, Dr. Daniel G. Schultz; Casey McGlynn, Chairman of the Life Sciences Group at WSGR; Mark Wan, Partner of Three Arch Partners and other seasoned medical technology experts. Mark Leahey, Executive Director of MDMA stated, “We are thrilled to bring together leaders in the medical technology industry to discuss the critical issues facing innovative companies.”

More information on the agenda, venue, accommodations and pricing can be found online at www.medicaldevices.org, or by calling MDMA at (202) 354-7172.

###

The Medical Device Manufacturers Association (MDMA) is a national trade association based in Washington, D.C., representing innovators and entrepreneurs in the medical device industry. MDMA seeks to improve the quality of patient care by encouraging the development of new medical technology and fostering the availability of innovative products in the marketplace.